慢性阻塞性肺疾病合并呼吸衰竭的临床疗效观察.docVIP

精品论文 参考文献 慢性阻塞性肺疾病合并呼吸衰竭的临床疗效观察 黑龙江省海伦市红光农场医院 黑龙江 海伦市 152343 【摘 要】目的：探究慢性阻塞性肺疾病合并呼吸衰竭的临床治疗方法及效果。方法 ：以本院收治的42例慢性阻塞性肺疾病合并呼吸衰竭的患者为研究对象，随机分为对照组和观察组，每组各 21 例。对照组患者给予常规的支气管扩张治疗、氧疗等； 观察组在对照组治疗方法的基础上加用了莫西沙星溶液雾化吸入。治疗 14d，观察两组的疗效、患者的主要体测数据等。结果：治疗 14d 后，观察组治疗效果明显好于对照组，差异有统计学意义(P＜0.05) 。两组体温、白细胞计数(WBC)、呼吸(RR)、心率(HR)、血氧饱和度(SaO2)、氧合指数(PaO2/ FiO2) 比较，差异均有统计学意义(P＜0.05) 。结论：对慢性阻塞性肺疾病合并呼吸衰竭的治疗中采用常规治疗配合下的莫西沙星雾化吸入疗法，对于提高其有效率具有积极意义，值得继续推广应用。 【关键词】肺疾病；慢性阻塞性；呼吸衰竭 Efficacy of Respiratory Therapy in Patients with Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure 【Abstract】Objective: To explore the clinical treatment and efficacy of chronic obstructive pulmonary disease with respiratory failure. Methods: 42 patients with chronic obstructive pulmonary disease (COPD) complicated with respiratory failure were randomly divided into control group and observation group (n = 21). The patients in the control group were treated with conventional bronchodilator, oxygen therapy and so on. In the observation group, moxifloxacin solution inhalation was added in the control group based on the treatment. Treatment 14d, observed the efficacy of the two groups, the patients main physical measurement data. Results: After treatment for 14 days, the treatment group was significantly better than the control group, the difference was statistically significant (P lt;0.05). There were significant differences in body temperature, WBC, RR, HR, SaO2 and PaO2 / FiO2 between the two groups (P lt;0.05). Conclusion: Moxifloxacin aerosol inhalation therapy in chronic obstructive pulmonary disease complicated with respiratory failure is of positive significance to improve its efficiency, and it is worthy to be popularized and applied. 【Key words】Pulmonary disease; Chronic obstructive; Respiratory failure 【中图分类号】R563.9 【文献标识码】A 【文章编号】2096-0867（2016）14-092-01 慢性阻塞性肺疾病中呼吸衰竭是其主要的一种并发症，而在合并有呼吸衰竭的慢性阻塞性肺疾病的发病过程当中患者的气道往往会受限，影响到了正常的通气、呼吸功能，造成机体内氧分压 (PaO2)降低的同时二氧化碳分压(PaCO2)升高，严重的还会导致患者死亡。目前的临